Global Peptide CDMO Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Peptide CDMO market size was valued at US$ 3104.8 million in 2023. With growing demand in downstream market, the Peptide CDMO is forecast to a readjusted size of US$ 8518 million by 2030 with a CAGR of 15.5% during review period.
The research report highlights the growth potential of the global Peptide CDMO market. Peptide CDMO are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peptide CDMO. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peptide CDMO market.
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.
Global key peptide CDMO producers include Bachem, PolyPeptide, CordenPharma, and others. The top five manufacturers together account for 40% of the market share, with the largest manufacturer being Bachem with 17%. At the sales level, North America is the largest sales market with a market share of over 50%, followed by Europe and China with 33% and 9% respectively. In terms of product categories, it is divided into APIs and intermediates and FDF, with the former holding the major market share of 67%. In terms of application, commercial is the top application area with a market share of 76%, followed by academic research institutions.
Key Features:
The report on Peptide CDMO market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peptide CDMO market. It may include historical data, market segmentation by Type (e.g., APIs and Intermediates, FDF), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peptide CDMO market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peptide CDMO market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peptide CDMO industry. This include advancements in Peptide CDMO technology, Peptide CDMO new entrants, Peptide CDMO new investment, and other innovations that are shaping the future of Peptide CDMO.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peptide CDMO market. It includes factors influencing customer ' purchasing decisions, preferences for Peptide CDMO product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peptide CDMO market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peptide CDMO market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peptide CDMO market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peptide CDMO industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peptide CDMO market.
Market Segmentation:
Peptide CDMO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Peptide CDMO market size was valued at US$ 3104.8 million in 2023. With growing demand in downstream market, the Peptide CDMO is forecast to a readjusted size of US$ 8518 million by 2030 with a CAGR of 15.5% during review period.
The research report highlights the growth potential of the global Peptide CDMO market. Peptide CDMO are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peptide CDMO. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peptide CDMO market.
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.
Global key peptide CDMO producers include Bachem, PolyPeptide, CordenPharma, and others. The top five manufacturers together account for 40% of the market share, with the largest manufacturer being Bachem with 17%. At the sales level, North America is the largest sales market with a market share of over 50%, followed by Europe and China with 33% and 9% respectively. In terms of product categories, it is divided into APIs and intermediates and FDF, with the former holding the major market share of 67%. In terms of application, commercial is the top application area with a market share of 76%, followed by academic research institutions.
Key Features:
The report on Peptide CDMO market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peptide CDMO market. It may include historical data, market segmentation by Type (e.g., APIs and Intermediates, FDF), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peptide CDMO market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peptide CDMO market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peptide CDMO industry. This include advancements in Peptide CDMO technology, Peptide CDMO new entrants, Peptide CDMO new investment, and other innovations that are shaping the future of Peptide CDMO.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peptide CDMO market. It includes factors influencing customer ' purchasing decisions, preferences for Peptide CDMO product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peptide CDMO market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peptide CDMO market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peptide CDMO market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peptide CDMO industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peptide CDMO market.
Market Segmentation:
Peptide CDMO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- APIs and Intermediates
- FDF
- Commercial
- Academic Research
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bachem
- PolyPeptide
- CordenPharma
- AmbioPharm
- USV Peptides
- Thermofischer
- Bio Basic
- JPT
- Genscript
- Xinbang Pharma
- ScinoPharm
- SN Biopharm
- CBL
- Piramal Pharma
- CPC Scientific
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide CDMO Market Size 2019-2030
2.1.2 Peptide CDMO Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Peptide CDMO Segment by Type
2.2.1 APIs and Intermediates
2.2.2 FDF
2.3 Peptide CDMO Market Size by Type
2.3.1 Peptide CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Peptide CDMO Market Size Market Share by Type (2019-2024)
2.4 Peptide CDMO Segment by Application
2.4.1 Commercial
2.4.2 Academic Research
2.4.3 Other
2.5 Peptide CDMO Market Size by Application
2.5.1 Peptide CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Peptide CDMO Market Size Market Share by Application (2019-2024)
3 PEPTIDE CDMO MARKET SIZE BY PLAYER
3.1 Peptide CDMO Market Size Market Share by Players
3.1.1 Global Peptide CDMO Revenue by Players (2019-2024)
3.1.2 Global Peptide CDMO Revenue Market Share by Players (2019-2024)
3.2 Global Peptide CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE CDMO BY REGIONS
4.1 Peptide CDMO Market Size by Regions (2019-2024)
4.2 Americas Peptide CDMO Market Size Growth (2019-2024)
4.3 APAC Peptide CDMO Market Size Growth (2019-2024)
4.4 Europe Peptide CDMO Market Size Growth (2019-2024)
4.5 Middle East & Africa Peptide CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Peptide CDMO Market Size by Country (2019-2024)
5.2 Americas Peptide CDMO Market Size by Type (2019-2024)
5.3 Americas Peptide CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide CDMO Market Size by Region (2019-2024)
6.2 APAC Peptide CDMO Market Size by Type (2019-2024)
6.3 APAC Peptide CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide CDMO by Country (2019-2024)
7.2 Europe Peptide CDMO Market Size by Type (2019-2024)
7.3 Europe Peptide CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide CDMO by Region (2019-2024)
8.2 Middle East & Africa Peptide CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Peptide CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE CDMO MARKET FORECAST
10.1 Global Peptide CDMO Forecast by Regions (2025-2030)
10.1.1 Global Peptide CDMO Forecast by Regions (2025-2030)
10.1.2 Americas Peptide CDMO Forecast
10.1.3 APAC Peptide CDMO Forecast
10.1.4 Europe Peptide CDMO Forecast
10.1.5 Middle East & Africa Peptide CDMO Forecast
10.2 Americas Peptide CDMO Forecast by Country (2025-2030)
10.2.1 United States Peptide CDMO Market Forecast
10.2.2 Canada Peptide CDMO Market Forecast
10.2.3 Mexico Peptide CDMO Market Forecast
10.2.4 Brazil Peptide CDMO Market Forecast
10.3 APAC Peptide CDMO Forecast by Region (2025-2030)
10.3.1 China Peptide CDMO Market Forecast
10.3.2 Japan Peptide CDMO Market Forecast
10.3.3 Korea Peptide CDMO Market Forecast
10.3.4 Southeast Asia Peptide CDMO Market Forecast
10.3.5 India Peptide CDMO Market Forecast
10.3.6 Australia Peptide CDMO Market Forecast
10.4 Europe Peptide CDMO Forecast by Country (2025-2030)
10.4.1 Germany Peptide CDMO Market Forecast
10.4.2 France Peptide CDMO Market Forecast
10.4.3 UK Peptide CDMO Market Forecast
10.4.4 Italy Peptide CDMO Market Forecast
10.4.5 Russia Peptide CDMO Market Forecast
10.5 Middle East & Africa Peptide CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Peptide CDMO Market Forecast
10.5.2 South Africa Peptide CDMO Market Forecast
10.5.3 Israel Peptide CDMO Market Forecast
10.5.4 Turkey Peptide CDMO Market Forecast
10.5.5 GCC Countries Peptide CDMO Market Forecast
10.6 Global Peptide CDMO Forecast by Type (2025-2030)
10.7 Global Peptide CDMO Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bachem
11.1.1 Bachem Company Information
11.1.2 Bachem Peptide CDMO Product Offered
11.1.3 Bachem Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bachem Main Business Overview
11.1.5 Bachem Latest Developments
11.2 PolyPeptide
11.2.1 PolyPeptide Company Information
11.2.2 PolyPeptide Peptide CDMO Product Offered
11.2.3 PolyPeptide Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 PolyPeptide Main Business Overview
11.2.5 PolyPeptide Latest Developments
11.3 CordenPharma
11.3.1 CordenPharma Company Information
11.3.2 CordenPharma Peptide CDMO Product Offered
11.3.3 CordenPharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 CordenPharma Main Business Overview
11.3.5 CordenPharma Latest Developments
11.4 AmbioPharm
11.4.1 AmbioPharm Company Information
11.4.2 AmbioPharm Peptide CDMO Product Offered
11.4.3 AmbioPharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AmbioPharm Main Business Overview
11.4.5 AmbioPharm Latest Developments
11.5 USV Peptides
11.5.1 USV Peptides Company Information
11.5.2 USV Peptides Peptide CDMO Product Offered
11.5.3 USV Peptides Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 USV Peptides Main Business Overview
11.5.5 USV Peptides Latest Developments
11.6 Thermofischer
11.6.1 Thermofischer Company Information
11.6.2 Thermofischer Peptide CDMO Product Offered
11.6.3 Thermofischer Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Thermofischer Main Business Overview
11.6.5 Thermofischer Latest Developments
11.7 Bio Basic
11.7.1 Bio Basic Company Information
11.7.2 Bio Basic Peptide CDMO Product Offered
11.7.3 Bio Basic Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bio Basic Main Business Overview
11.7.5 Bio Basic Latest Developments
11.8 JPT
11.8.1 JPT Company Information
11.8.2 JPT Peptide CDMO Product Offered
11.8.3 JPT Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 JPT Main Business Overview
11.8.5 JPT Latest Developments
11.9 Genscript
11.9.1 Genscript Company Information
11.9.2 Genscript Peptide CDMO Product Offered
11.9.3 Genscript Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Genscript Main Business Overview
11.9.5 Genscript Latest Developments
11.10 Xinbang Pharma
11.10.1 Xinbang Pharma Company Information
11.10.2 Xinbang Pharma Peptide CDMO Product Offered
11.10.3 Xinbang Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Xinbang Pharma Main Business Overview
11.10.5 Xinbang Pharma Latest Developments
11.11 ScinoPharm
11.11.1 ScinoPharm Company Information
11.11.2 ScinoPharm Peptide CDMO Product Offered
11.11.3 ScinoPharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 ScinoPharm Main Business Overview
11.11.5 ScinoPharm Latest Developments
11.12 SN Biopharm
11.12.1 SN Biopharm Company Information
11.12.2 SN Biopharm Peptide CDMO Product Offered
11.12.3 SN Biopharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 SN Biopharm Main Business Overview
11.12.5 SN Biopharm Latest Developments
11.13 CBL
11.13.1 CBL Company Information
11.13.2 CBL Peptide CDMO Product Offered
11.13.3 CBL Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 CBL Main Business Overview
11.13.5 CBL Latest Developments
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Information
11.14.2 Piramal Pharma Peptide CDMO Product Offered
11.14.3 Piramal Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Piramal Pharma Main Business Overview
11.14.5 Piramal Pharma Latest Developments
11.15 CPC Scientific
11.15.1 CPC Scientific Company Information
11.15.2 CPC Scientific Peptide CDMO Product Offered
11.15.3 CPC Scientific Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 CPC Scientific Main Business Overview
11.15.5 CPC Scientific Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide CDMO Market Size 2019-2030
2.1.2 Peptide CDMO Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Peptide CDMO Segment by Type
2.2.1 APIs and Intermediates
2.2.2 FDF
2.3 Peptide CDMO Market Size by Type
2.3.1 Peptide CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Peptide CDMO Market Size Market Share by Type (2019-2024)
2.4 Peptide CDMO Segment by Application
2.4.1 Commercial
2.4.2 Academic Research
2.4.3 Other
2.5 Peptide CDMO Market Size by Application
2.5.1 Peptide CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Peptide CDMO Market Size Market Share by Application (2019-2024)
3 PEPTIDE CDMO MARKET SIZE BY PLAYER
3.1 Peptide CDMO Market Size Market Share by Players
3.1.1 Global Peptide CDMO Revenue by Players (2019-2024)
3.1.2 Global Peptide CDMO Revenue Market Share by Players (2019-2024)
3.2 Global Peptide CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE CDMO BY REGIONS
4.1 Peptide CDMO Market Size by Regions (2019-2024)
4.2 Americas Peptide CDMO Market Size Growth (2019-2024)
4.3 APAC Peptide CDMO Market Size Growth (2019-2024)
4.4 Europe Peptide CDMO Market Size Growth (2019-2024)
4.5 Middle East & Africa Peptide CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Peptide CDMO Market Size by Country (2019-2024)
5.2 Americas Peptide CDMO Market Size by Type (2019-2024)
5.3 Americas Peptide CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide CDMO Market Size by Region (2019-2024)
6.2 APAC Peptide CDMO Market Size by Type (2019-2024)
6.3 APAC Peptide CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide CDMO by Country (2019-2024)
7.2 Europe Peptide CDMO Market Size by Type (2019-2024)
7.3 Europe Peptide CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide CDMO by Region (2019-2024)
8.2 Middle East & Africa Peptide CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Peptide CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE CDMO MARKET FORECAST
10.1 Global Peptide CDMO Forecast by Regions (2025-2030)
10.1.1 Global Peptide CDMO Forecast by Regions (2025-2030)
10.1.2 Americas Peptide CDMO Forecast
10.1.3 APAC Peptide CDMO Forecast
10.1.4 Europe Peptide CDMO Forecast
10.1.5 Middle East & Africa Peptide CDMO Forecast
10.2 Americas Peptide CDMO Forecast by Country (2025-2030)
10.2.1 United States Peptide CDMO Market Forecast
10.2.2 Canada Peptide CDMO Market Forecast
10.2.3 Mexico Peptide CDMO Market Forecast
10.2.4 Brazil Peptide CDMO Market Forecast
10.3 APAC Peptide CDMO Forecast by Region (2025-2030)
10.3.1 China Peptide CDMO Market Forecast
10.3.2 Japan Peptide CDMO Market Forecast
10.3.3 Korea Peptide CDMO Market Forecast
10.3.4 Southeast Asia Peptide CDMO Market Forecast
10.3.5 India Peptide CDMO Market Forecast
10.3.6 Australia Peptide CDMO Market Forecast
10.4 Europe Peptide CDMO Forecast by Country (2025-2030)
10.4.1 Germany Peptide CDMO Market Forecast
10.4.2 France Peptide CDMO Market Forecast
10.4.3 UK Peptide CDMO Market Forecast
10.4.4 Italy Peptide CDMO Market Forecast
10.4.5 Russia Peptide CDMO Market Forecast
10.5 Middle East & Africa Peptide CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Peptide CDMO Market Forecast
10.5.2 South Africa Peptide CDMO Market Forecast
10.5.3 Israel Peptide CDMO Market Forecast
10.5.4 Turkey Peptide CDMO Market Forecast
10.5.5 GCC Countries Peptide CDMO Market Forecast
10.6 Global Peptide CDMO Forecast by Type (2025-2030)
10.7 Global Peptide CDMO Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bachem
11.1.1 Bachem Company Information
11.1.2 Bachem Peptide CDMO Product Offered
11.1.3 Bachem Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bachem Main Business Overview
11.1.5 Bachem Latest Developments
11.2 PolyPeptide
11.2.1 PolyPeptide Company Information
11.2.2 PolyPeptide Peptide CDMO Product Offered
11.2.3 PolyPeptide Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 PolyPeptide Main Business Overview
11.2.5 PolyPeptide Latest Developments
11.3 CordenPharma
11.3.1 CordenPharma Company Information
11.3.2 CordenPharma Peptide CDMO Product Offered
11.3.3 CordenPharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 CordenPharma Main Business Overview
11.3.5 CordenPharma Latest Developments
11.4 AmbioPharm
11.4.1 AmbioPharm Company Information
11.4.2 AmbioPharm Peptide CDMO Product Offered
11.4.3 AmbioPharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AmbioPharm Main Business Overview
11.4.5 AmbioPharm Latest Developments
11.5 USV Peptides
11.5.1 USV Peptides Company Information
11.5.2 USV Peptides Peptide CDMO Product Offered
11.5.3 USV Peptides Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 USV Peptides Main Business Overview
11.5.5 USV Peptides Latest Developments
11.6 Thermofischer
11.6.1 Thermofischer Company Information
11.6.2 Thermofischer Peptide CDMO Product Offered
11.6.3 Thermofischer Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Thermofischer Main Business Overview
11.6.5 Thermofischer Latest Developments
11.7 Bio Basic
11.7.1 Bio Basic Company Information
11.7.2 Bio Basic Peptide CDMO Product Offered
11.7.3 Bio Basic Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bio Basic Main Business Overview
11.7.5 Bio Basic Latest Developments
11.8 JPT
11.8.1 JPT Company Information
11.8.2 JPT Peptide CDMO Product Offered
11.8.3 JPT Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 JPT Main Business Overview
11.8.5 JPT Latest Developments
11.9 Genscript
11.9.1 Genscript Company Information
11.9.2 Genscript Peptide CDMO Product Offered
11.9.3 Genscript Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Genscript Main Business Overview
11.9.5 Genscript Latest Developments
11.10 Xinbang Pharma
11.10.1 Xinbang Pharma Company Information
11.10.2 Xinbang Pharma Peptide CDMO Product Offered
11.10.3 Xinbang Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Xinbang Pharma Main Business Overview
11.10.5 Xinbang Pharma Latest Developments
11.11 ScinoPharm
11.11.1 ScinoPharm Company Information
11.11.2 ScinoPharm Peptide CDMO Product Offered
11.11.3 ScinoPharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 ScinoPharm Main Business Overview
11.11.5 ScinoPharm Latest Developments
11.12 SN Biopharm
11.12.1 SN Biopharm Company Information
11.12.2 SN Biopharm Peptide CDMO Product Offered
11.12.3 SN Biopharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 SN Biopharm Main Business Overview
11.12.5 SN Biopharm Latest Developments
11.13 CBL
11.13.1 CBL Company Information
11.13.2 CBL Peptide CDMO Product Offered
11.13.3 CBL Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 CBL Main Business Overview
11.13.5 CBL Latest Developments
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Information
11.14.2 Piramal Pharma Peptide CDMO Product Offered
11.14.3 Piramal Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Piramal Pharma Main Business Overview
11.14.5 Piramal Pharma Latest Developments
11.15 CPC Scientific
11.15.1 CPC Scientific Company Information
11.15.2 CPC Scientific Peptide CDMO Product Offered
11.15.3 CPC Scientific Peptide CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 CPC Scientific Main Business Overview
11.15.5 CPC Scientific Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peptide CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of APIs and Intermediates
Table 3. Major Players of FDF
Table 4. Peptide CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Peptide CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Peptide CDMO Market Size Market Share by Type (2019-2024)
Table 7. Peptide CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Peptide CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Peptide CDMO Market Size Market Share by Application (2019-2024)
Table 10. Global Peptide CDMO Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Peptide CDMO Revenue Market Share by Player (2019-2024)
Table 12. Peptide CDMO Key Players Head office and Products Offered
Table 13. Peptide CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Peptide CDMO Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Peptide CDMO Market Size Market Share by Regions (2019-2024)
Table 18. Global Peptide CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Peptide CDMO Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Peptide CDMO Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Peptide CDMO Market Size Market Share by Country (2019-2024)
Table 22. Americas Peptide CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Peptide CDMO Market Size Market Share by Type (2019-2024)
Table 24. Americas Peptide CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Peptide CDMO Market Size Market Share by Application (2019-2024)
Table 26. APAC Peptide CDMO Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Peptide CDMO Market Size Market Share by Region (2019-2024)
Table 28. APAC Peptide CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Peptide CDMO Market Size Market Share by Type (2019-2024)
Table 30. APAC Peptide CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Peptide CDMO Market Size Market Share by Application (2019-2024)
Table 32. Europe Peptide CDMO Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Peptide CDMO Market Size Market Share by Country (2019-2024)
Table 34. Europe Peptide CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Peptide CDMO Market Size Market Share by Type (2019-2024)
Table 36. Europe Peptide CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Peptide CDMO Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Peptide CDMO Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Peptide CDMO Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Peptide CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Peptide CDMO Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Peptide CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Peptide CDMO Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Peptide CDMO
Table 45. Key Market Challenges & Risks of Peptide CDMO
Table 46. Key Industry Trends of Peptide CDMO
Table 47. Global Peptide CDMO Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Peptide CDMO Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Peptide CDMO Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Peptide CDMO Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Bachem Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 52. Bachem Peptide CDMO Product Offered
Table 53. Bachem Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Bachem Main Business
Table 55. Bachem Latest Developments
Table 56. PolyPeptide Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 57. PolyPeptide Peptide CDMO Product Offered
Table 58. PolyPeptide Main Business
Table 59. PolyPeptide Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. PolyPeptide Latest Developments
Table 61. CordenPharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 62. CordenPharma Peptide CDMO Product Offered
Table 63. CordenPharma Main Business
Table 64. CordenPharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. CordenPharma Latest Developments
Table 66. AmbioPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 67. AmbioPharm Peptide CDMO Product Offered
Table 68. AmbioPharm Main Business
Table 69. AmbioPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. AmbioPharm Latest Developments
Table 71. USV Peptides Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 72. USV Peptides Peptide CDMO Product Offered
Table 73. USV Peptides Main Business
Table 74. USV Peptides Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. USV Peptides Latest Developments
Table 76. Thermofischer Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 77. Thermofischer Peptide CDMO Product Offered
Table 78. Thermofischer Main Business
Table 79. Thermofischer Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Thermofischer Latest Developments
Table 81. Bio Basic Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 82. Bio Basic Peptide CDMO Product Offered
Table 83. Bio Basic Main Business
Table 84. Bio Basic Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Bio Basic Latest Developments
Table 86. JPT Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 87. JPT Peptide CDMO Product Offered
Table 88. JPT Main Business
Table 89. JPT Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. JPT Latest Developments
Table 91. Genscript Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 92. Genscript Peptide CDMO Product Offered
Table 93. Genscript Main Business
Table 94. Genscript Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Genscript Latest Developments
Table 96. Xinbang Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 97. Xinbang Pharma Peptide CDMO Product Offered
Table 98. Xinbang Pharma Main Business
Table 99. Xinbang Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Xinbang Pharma Latest Developments
Table 101. ScinoPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 102. ScinoPharm Peptide CDMO Product Offered
Table 103. ScinoPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. ScinoPharm Main Business
Table 105. ScinoPharm Latest Developments
Table 106. SN Biopharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 107. SN Biopharm Peptide CDMO Product Offered
Table 108. SN Biopharm Main Business
Table 109. SN Biopharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. SN Biopharm Latest Developments
Table 111. CBL Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 112. CBL Peptide CDMO Product Offered
Table 113. CBL Main Business
Table 114. CBL Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. CBL Latest Developments
Table 116. Piramal Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 117. Piramal Pharma Peptide CDMO Product Offered
Table 118. Piramal Pharma Main Business
Table 119. Piramal Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Piramal Pharma Latest Developments
Table 121. CPC Scientific Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 122. CPC Scientific Peptide CDMO Product Offered
Table 123. CPC Scientific Main Business
Table 124. CPC Scientific Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. CPC Scientific Latest Developments
Table 1. Peptide CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of APIs and Intermediates
Table 3. Major Players of FDF
Table 4. Peptide CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Peptide CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Peptide CDMO Market Size Market Share by Type (2019-2024)
Table 7. Peptide CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Peptide CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Peptide CDMO Market Size Market Share by Application (2019-2024)
Table 10. Global Peptide CDMO Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Peptide CDMO Revenue Market Share by Player (2019-2024)
Table 12. Peptide CDMO Key Players Head office and Products Offered
Table 13. Peptide CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Peptide CDMO Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Peptide CDMO Market Size Market Share by Regions (2019-2024)
Table 18. Global Peptide CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Peptide CDMO Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Peptide CDMO Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Peptide CDMO Market Size Market Share by Country (2019-2024)
Table 22. Americas Peptide CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Peptide CDMO Market Size Market Share by Type (2019-2024)
Table 24. Americas Peptide CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Peptide CDMO Market Size Market Share by Application (2019-2024)
Table 26. APAC Peptide CDMO Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Peptide CDMO Market Size Market Share by Region (2019-2024)
Table 28. APAC Peptide CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Peptide CDMO Market Size Market Share by Type (2019-2024)
Table 30. APAC Peptide CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Peptide CDMO Market Size Market Share by Application (2019-2024)
Table 32. Europe Peptide CDMO Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Peptide CDMO Market Size Market Share by Country (2019-2024)
Table 34. Europe Peptide CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Peptide CDMO Market Size Market Share by Type (2019-2024)
Table 36. Europe Peptide CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Peptide CDMO Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Peptide CDMO Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Peptide CDMO Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Peptide CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Peptide CDMO Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Peptide CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Peptide CDMO Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Peptide CDMO
Table 45. Key Market Challenges & Risks of Peptide CDMO
Table 46. Key Industry Trends of Peptide CDMO
Table 47. Global Peptide CDMO Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Peptide CDMO Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Peptide CDMO Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Peptide CDMO Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Bachem Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 52. Bachem Peptide CDMO Product Offered
Table 53. Bachem Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Bachem Main Business
Table 55. Bachem Latest Developments
Table 56. PolyPeptide Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 57. PolyPeptide Peptide CDMO Product Offered
Table 58. PolyPeptide Main Business
Table 59. PolyPeptide Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. PolyPeptide Latest Developments
Table 61. CordenPharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 62. CordenPharma Peptide CDMO Product Offered
Table 63. CordenPharma Main Business
Table 64. CordenPharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. CordenPharma Latest Developments
Table 66. AmbioPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 67. AmbioPharm Peptide CDMO Product Offered
Table 68. AmbioPharm Main Business
Table 69. AmbioPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. AmbioPharm Latest Developments
Table 71. USV Peptides Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 72. USV Peptides Peptide CDMO Product Offered
Table 73. USV Peptides Main Business
Table 74. USV Peptides Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. USV Peptides Latest Developments
Table 76. Thermofischer Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 77. Thermofischer Peptide CDMO Product Offered
Table 78. Thermofischer Main Business
Table 79. Thermofischer Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Thermofischer Latest Developments
Table 81. Bio Basic Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 82. Bio Basic Peptide CDMO Product Offered
Table 83. Bio Basic Main Business
Table 84. Bio Basic Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Bio Basic Latest Developments
Table 86. JPT Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 87. JPT Peptide CDMO Product Offered
Table 88. JPT Main Business
Table 89. JPT Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. JPT Latest Developments
Table 91. Genscript Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 92. Genscript Peptide CDMO Product Offered
Table 93. Genscript Main Business
Table 94. Genscript Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Genscript Latest Developments
Table 96. Xinbang Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 97. Xinbang Pharma Peptide CDMO Product Offered
Table 98. Xinbang Pharma Main Business
Table 99. Xinbang Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Xinbang Pharma Latest Developments
Table 101. ScinoPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 102. ScinoPharm Peptide CDMO Product Offered
Table 103. ScinoPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. ScinoPharm Main Business
Table 105. ScinoPharm Latest Developments
Table 106. SN Biopharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 107. SN Biopharm Peptide CDMO Product Offered
Table 108. SN Biopharm Main Business
Table 109. SN Biopharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. SN Biopharm Latest Developments
Table 111. CBL Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 112. CBL Peptide CDMO Product Offered
Table 113. CBL Main Business
Table 114. CBL Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. CBL Latest Developments
Table 116. Piramal Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 117. Piramal Pharma Peptide CDMO Product Offered
Table 118. Piramal Pharma Main Business
Table 119. Piramal Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Piramal Pharma Latest Developments
Table 121. CPC Scientific Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 122. CPC Scientific Peptide CDMO Product Offered
Table 123. CPC Scientific Main Business
Table 124. CPC Scientific Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. CPC Scientific Latest Developments
LIST OF FIGURES
Figure 1. Peptide CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide CDMO Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Peptide CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Peptide CDMO Sales Market Share by Country/Region (2023)
Figure 8. Peptide CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Peptide CDMO Market Size Market Share by Type in 2023
Figure 10. Peptide CDMO in Commercial
Figure 11. Global Peptide CDMO Market: Commercial (2019-2024) & ($ Millions)
Figure 12. Peptide CDMO in Academic Research
Figure 13. Global Peptide CDMO Market: Academic Research (2019-2024) & ($ Millions)
Figure 14. Peptide CDMO in Other
Figure 15. Global Peptide CDMO Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Peptide CDMO Market Size Market Share by Application in 2023
Figure 17. Global Peptide CDMO Revenue Market Share by Player in 2023
Figure 18. Global Peptide CDMO Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Peptide CDMO Market Size 2019-2024 ($ Millions)
Figure 20. APAC Peptide CDMO Market Size 2019-2024 ($ Millions)
Figure 21. Europe Peptide CDMO Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Peptide CDMO Market Size 2019-2024 ($ Millions)
Figure 23. Americas Peptide CDMO Value Market Share by Country in 2023
Figure 24. United States Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Peptide CDMO Market Size Market Share by Region in 2023
Figure 29. APAC Peptide CDMO Market Size Market Share by Type in 2023
Figure 30. APAC Peptide CDMO Market Size Market Share by Application in 2023
Figure 31. China Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Peptide CDMO Market Size Market Share by Country in 2023
Figure 38. Europe Peptide CDMO Market Size Market Share by Type (2019-2024)
Figure 39. Europe Peptide CDMO Market Size Market Share by Application (2019-2024)
Figure 40. Germany Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Peptide CDMO Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Peptide CDMO Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Peptide CDMO Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 54. APAC Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 55. Europe Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 57. United States Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 58. Canada Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 61. China Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 62. Japan Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 63. Korea Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 65. India Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 66. Australia Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 67. Germany Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 68. France Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 69. UK Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 70. Italy Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 71. Russia Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 72. Spain Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 75. Israel Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 78. Global Peptide CDMO Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Peptide CDMO Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Peptide CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide CDMO Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Peptide CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Peptide CDMO Sales Market Share by Country/Region (2023)
Figure 8. Peptide CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Peptide CDMO Market Size Market Share by Type in 2023
Figure 10. Peptide CDMO in Commercial
Figure 11. Global Peptide CDMO Market: Commercial (2019-2024) & ($ Millions)
Figure 12. Peptide CDMO in Academic Research
Figure 13. Global Peptide CDMO Market: Academic Research (2019-2024) & ($ Millions)
Figure 14. Peptide CDMO in Other
Figure 15. Global Peptide CDMO Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Peptide CDMO Market Size Market Share by Application in 2023
Figure 17. Global Peptide CDMO Revenue Market Share by Player in 2023
Figure 18. Global Peptide CDMO Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Peptide CDMO Market Size 2019-2024 ($ Millions)
Figure 20. APAC Peptide CDMO Market Size 2019-2024 ($ Millions)
Figure 21. Europe Peptide CDMO Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Peptide CDMO Market Size 2019-2024 ($ Millions)
Figure 23. Americas Peptide CDMO Value Market Share by Country in 2023
Figure 24. United States Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Peptide CDMO Market Size Market Share by Region in 2023
Figure 29. APAC Peptide CDMO Market Size Market Share by Type in 2023
Figure 30. APAC Peptide CDMO Market Size Market Share by Application in 2023
Figure 31. China Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Peptide CDMO Market Size Market Share by Country in 2023
Figure 38. Europe Peptide CDMO Market Size Market Share by Type (2019-2024)
Figure 39. Europe Peptide CDMO Market Size Market Share by Application (2019-2024)
Figure 40. Germany Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Peptide CDMO Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Peptide CDMO Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Peptide CDMO Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Peptide CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 54. APAC Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 55. Europe Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 57. United States Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 58. Canada Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 61. China Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 62. Japan Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 63. Korea Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 65. India Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 66. Australia Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 67. Germany Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 68. France Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 69. UK Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 70. Italy Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 71. Russia Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 72. Spain Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 75. Israel Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Peptide CDMO Market Size 2025-2030 ($ Millions)
Figure 78. Global Peptide CDMO Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Peptide CDMO Market Size Market Share Forecast by Application (2025-2030)
